Florquinitau F-18 Patent Expiration
Florquinitau F-18 was first introduced by Cerveau Technologies Inc A Lantheus Co
Florquinitau F-18 Patents
Given below is the list of patents protecting Florquinitau F-18, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Tauklarify | US10022461 | Pyrrolo[2,3-C]Pyridines As Imaging Agents For Neurofibrilary Tangles | Jun 09, 2035 | Cerveau Lantheus |
| Tauklarify | US9808542 | Pyrrolo[2,3-C]Pyridines As Imaging Agents For Neurofibrillary | Jun 09, 2035 | Cerveau Lantheus |
Florquinitau F-18's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List